Chris Carswell
@PECjournal
Followers
2K
Following
2K
Media
194
Statuses
10K
Editor in Chief PharmacoEconomics. Past President ISPOR NZ Chapter, ex pharmacist, run and play the piano. UK expat in New Zealand. All views are my own
New Zealand
Joined January 2010
RT @jemimahride: I’ll be attending the @AusHealthEcon conference this week in Sydney, so feel free to chat to me there about this job if yo….
linkedin.com
Today's top 1,000+ Academic Researcher jobs in United States. Leverage your professional network, and get hired. New Academic Researcher jobs added daily.
0
2
0
PharmacoEconomics has a Call For Papers for a themed issue on individual level models
link.springer.com
Pharmacoeconomics invites the submission of papers (original research, reviews, and tutorial pieces) on developing and using individual-level models for ...
0
1
2
RT @PatientJournal: A much needed reporting checklist for discrete choice experiments
link.springer.com
PharmacoEconomics - Reporting standards of discrete choice experiments (DCEs) in health have not kept pace with the growth of this method, with multiple reviews calling for better reporting to...
0
3
0
RT @jemimahride: If you read, write or review papers on discrete choice experiments in health & healthcare, you may have noticed that repor….
link.springer.com
PharmacoEconomics - Reporting standards of discrete choice experiments (DCEs) in health have not kept pace with the growth of this method, with multiple reviews calling for better reporting to...
0
7
0
RT @newsvava: Second, this solo editorial in Pharmacoeconomics, called "Making Models Fit for Purpose: the Importance of Ensuring Stakehold….
0
3
0
RT @mikepaulden: My 'Framework for the Fair Pricing of Medicines' has just been published as a Leading Article by Pharmacoeconomics. This f….
link.springer.com
PharmacoEconomics - As high-cost medicines put increasing pressure on public health care budgets, the need to identify ‘fair’ prices for medicines has never been greater. This paper...
0
9
0
RT @HajBrum: Including carer outcomes in economic evaluation is important & can reveal unrecognised challenges in HTA decisions. One of th….
link.springer.com
PharmacoEconomics - The provision of informal (unpaid) care can impose significant ‘spillover effects’ on carers, and accounting for these effects is consistent with the efficiency and...
0
18
0
RT @nancydevlin1: 1/3 "Using Age-Specific Values for Pediatric HRQoL in CEA: Is There a Problem to Be Solved? If So, How?" available here👉….
0
10
0
RT @stolk_elly: Happy to see this work published with @nancydevlin1 @tianxinpan @MJSculpher @markjit @donna_rowen Ben van Hout and @rich_no….
0
10
0
RT @catebailey1: Thread update on the QUOKKA project led by the brilliant @nancydevlin1 - huge output from this multi-university project on….
0
2
0
RT @ZANFINA: Congratulations @dinaabushanab10 on this massive work on projecting the health and economic burden of CVD among people with ty….
link.springer.com
PharmacoEconomics - The aim was to project the health and economic outcomes of cardiovascular disease (CVD) among people with type 2 diabetes from Australian public healthcare and societal...
0
4
0
RT @ddkim62: In preparation for my new class @HarrisPolicy, I asked ChatGPT: . “How to conduct cost-effectiveness analysis (CEA)?”. ChatGPT….
0
4
0
RT @jamesfomahony: At @ipha's conference. The Minister just mentioned Ireland's €45,000/QALY threshold and that there is an existing pathwa….
0
1
0
RT @BCNHealth: @BCNHealth publishes a study reviewing economic evaluations and burden of disease studies of endometriosis.#health #review #….
0
3
0
RT @NICEComms: Antimicrobial resistance or #AMR, as known in short, is a global health crisis. Find out how we're applying a new 'Netflix'….
link.springer.com
Applied Health Economics and Health Policy - The silent pandemic of antimicrobial resistance (AMR) is a global issue needing prompt attention. A comprehensive one-health approach across human and...
0
11
0
RT @sebh2005: Long shot but are there any health economist out there would would review a journal paper for me? My last PhD by publication….
0
11
0